Company Filing History:
Years Active: 2017-2020
Title: Innovations of Guang Jin Choi in Interleukin-2 Production
Introduction
Guang Jin Choi is an accomplished inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of interleukin-2 proteins. With a total of three patents to his name, Choi's work has the potential to impact medical research and therapeutic applications.
Latest Patents
Choi's latest patents include a method for producing interleukin-2 protein using methylotrophic yeast. This innovative method demonstrates high cell growth and protein synthesis rates by utilizing an established optimal cell line. It also allows for the production of large quantities of interleukin-2 by employing optimal culture conditions that utilize methanol as an inexpensive carbon source. Furthermore, the method isolates and purifies the protein through a simple process, resulting in highly pure interleukin-2, which is crucial for mass production.
Another notable patent is the interleukin-2 expression construct using human serum albumin. This construct comprises a methanol oxidase (MOX) promoter, a human serum albumin gene, and an interleukin-2 gene. The expression construct enables the production of a fusion protein of human serum albumin and interleukin-2 at low costs, facilitating the easy separation of recombinant interleukin-2 from the fusion protein. This innovation is expected to enhance the production of recombinant interleukin-2 with high purity.
Career Highlights
Choi is affiliated with the Soonchunhyang University Industry Academy Cooperation Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving biotechnological processes and outcomes.
Collaborations
Choi collaborates with notable colleagues, including Keon-Hyoung Song and Sang-Ki Rhee, who contribute to his research endeavors and innovations in the field.
Conclusion
Guang Jin Choi's contributions to the production of interleukin-2 proteins through innovative methods and constructs highlight his role as a significant inventor in biotechnology. His work not only advances scientific understanding but also has the potential to improve therapeutic applications in medicine.